Hyperglycemia is a predictor of mortality and morbidity in low birth weight newborn

Area of Science:

• Neonatalogy
• Endocrinology
• Perinatology

Background:

• Early-onset hyperglycemia is a frequent complication in low birth weight neonates.
• Hyperglycemic low birth weight infants face elevated risks of mortality and major morbidities.

Purpose of the Study:

• To investigate hyperglycemia as a predictor of increased morbidity and mortality in sick, low birth weight newborns.
• To assess the association between hyperglycemia and specific morbidities in this population.

Main Methods:

• A prospective observational study conducted in a Special Care Baby Unit (SCABU) in Dhaka, Bangladesh.
• Inclusion of 198 hospitalized low birth weight neonates between July and December 2009.
• Data collection on hyperglycemia, gestational age, birth weight, morbidities, and mortality.

Main Results:

• 30.8% of low birth weight neonates exhibited hyperglycemia, with higher prevalence in those with birth weight <1000gm and gestational age ≤28 weeks.
• Significant associations found between hyperglycemia and apnea, sepsis (confirmed and suspected), necrotizing enterocolitis (NEC), and neonatal jaundice.
• Mortality was substantially higher in the hyperglycemic group (31.15%) compared to the non-hyperglycemic group (10.22%), with statistical significance (p<0.002).

Conclusions:

• Hyperglycemia in the early neonatal period is a significant indicator of increased morbidity and mortality in low birth weight infants.
• The findings underscore the importance of monitoring glucose levels in vulnerable low birth weight neonates.
• Effective management of hyperglycemia may be key to reducing adverse outcomes in this population.